Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 11 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HRES 566. Clear
Clear
Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q2
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q1
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q1
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q4
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q3
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Trade (domestic/foreign), Health Issues
View → Q3
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN for THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
3rd Quarter (July 1 - Sep 30) 2025 · Texas · House · Senate
Budget/Appropriations, Insurance, Medicare/Medicaid, Health Issues
View → Q3
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Trade (domestic/foreign), Health Issues
View → Q2
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q2
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN for THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
2nd Quarter (Apr 1 - June 30) 2025 · Texas · House · Senate
Medicare/Medicaid, Budget/Appropriations, Insurance, Defense
View → Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem